Cited by 124Psychedelics and Drug StudiesForensic Toxicology and Drug AnalysisSubstance Abuse Treatment and Outcomes

Over 30 million psychedelic users in the United States

Open access
Krebs, Teri S, Johansen, Pål-Ørjan·2013·F1000Research

Abstract

We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12688/f1000research.2-98.v1

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An estimated 21 million people in the US use psilocybin, with some using it for recreational purposes and others for self-medication.

    “An estimated 21 million people in the US use psilocybin, with some stating they use it for recreational purposes and others for self-medication. 97”

    From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [97]

    The Results report an estimated 21 million US residents with lifetime psilocybin use in 2010, not 21 million current users. The Discussion mentions curiosity, mystical experiences, and introspection as reasons for psychedelic use, but our copy does not report recreational use or self-medication as reasons given by psilocybin users. (LLM, conf=0.89)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 5 · Cited by 124

Authors
Krebs, T. S., & Johansen, P.-Ø.
Affiliations
Norwegian University of Science and Technology (NO)
Corresponding author
Krebs, Teri S
Venue
F1000Research
Published
2013-03-28
Volume
2
Pages
98
ISSN
2046-1402 (ISSN-L)
OpenAlex
W2117522474
Cited by
124
References
5
Citations by year
2026: 9 · 2025: 10 · 2024: 13 · 2023: 10 · 2022: 18 · 2021: 23 · 2020: 9 · 2019: 9 · 2018: 6 · 2017: 7 · 2016: 6 · 2015: 1 · 2014: 1 · 2013: 2
FWCI
3.71
Type
journal article
Language
en
Open access
Locations
  • F1000Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Norges Forskningsråd (rcn-foriss-185924)
  • Substance Abuse and Mental Health Services Administration
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
psychedelic use, lifetime prevalence, LSD, psilocybin, magic mushrooms, mescaline, peyote, age differences, sex differences, drug use epidemiology, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review